Skip to collection list Skip to video grid
Skip to collection list Skip to video grid

Infectious Diseases

RSV Neutralizing Antibodies Following Nirsevimab and Palivizumab Dosing

This exploratory analysis from the phase 2/3 MEDLEY trial describes RSV neutralizing antibody levels associated with nirsevimab relative to palivizumab, the previous standard of care.

Click here to read the article
Read More
Read Less

categories

View more in
Infectious Diseases

Currently loaded videos are 1 through 15 of 98 total videos.

First page loaded, no previous page available
Load Next Page
3:38
Late-Onset Sepsis Among Extremely Preterm Infants During the COVID-19 Pandemic
Late-Onset Sepsis Among Extremely Preterm Infants During the COVID-19 Pandemic
4:13
Optimizing Management of Febrile Young Infants Without Serum Procalcitonin
Optimizing Management of Febrile Young Infants Without Serum Procalcitonin
3:54
Early and Long-Term Adverse Outcomes of In-Utero Zika Exposure
Early and Long-Term Adverse Outcomes of In-Utero Zika Exposure
4:09
Invalid Vaccine Doses Among Children Ages 0-35 months: 2011-2020
Invalid Vaccine Doses Among Children Ages 0-35 months: 2011-2020
4:06
Risk of Transmission of Vaccine-Strain Rotavirus in a NICU that Routinely Vaccinates
Risk of Transmission of Vaccine-Strain Rotavirus in a NICU that Routinely Vaccinates
4:15
Accuracy of Screening Tests for the Diagnosis of Urinary Tract Infection in Young Children
Accuracy of Screening Tests for the Diagnosis of Urinary Tract Infection in Young Children
4:07
RSV Neutralizing Antibodies Following Nirsevimab and Palivizumab Dosing
RSV Neutralizing Antibodies Following Nirsevimab and Palivizumab Dosing
4:12
Parental Preferences and Shared Decision-Making for the Management of Febrile Young Infants
Parental Preferences and Shared Decision-Making for the Management of Febrile Young Infants
3:45
Nirsevimab Effectiveness Against Severe RSV Infection in the Primary Care Setting
Nirsevimab Effectiveness Against Severe RSV Infection in the Primary Care Setting
4:08
Factors Associated with Perinatal Hepatitis C Screening Among Exposed Children: 2016-2020
Factors Associated with Perinatal Hepatitis C Screening Among Exposed Children: 2016-2020
4:13
Emergency Department Antibiotic Prescribing for Pediatric Urinary Tract Infections, 2011-2020
Emergency Department Antibiotic Prescribing for Pediatric Urinary Tract Infections, 2011-2020
4:05
Performance of Febrile Infant Algorithms by Duration of Fever
Performance of Febrile Infant Algorithms by Duration of Fever
4:06
Antimicrobial Stewardship Programs in Neonates: A Meta-Analysis
Antimicrobial Stewardship Programs in Neonates: A Meta-Analysis
4:07
Rate of Urinary Tract Infections, Bacteremia, and Meningitis in Preterm and Full Term Infants
Rate of Urinary Tract Infections, Bacteremia, and Meningitis in Preterm and Full Term Infants
4:16
Parent and Clinician Views on Not Using Antibiotics for Mild Community-Acquired Pneumonia
Parent and Clinician Views on Not Using Antibiotics for Mild Community-Acquired Pneumonia

Currently loaded videos are 1 through 15 of 98 total videos.

First page loaded, no previous page available
Load Next Page